EBV-associated lymphoproliferative disorders: classification and treatment.
about
The Role of Gammaherpesviruses in Cancer PathogenesisA lymphomagenic role for HIV beyond immune suppression?Orphan diseases of the nose and paranasal sinuses: Pathogenesis - clinic - therapyEpstein-Barr Virus-associated lymphoproliferative disorders: experimental and clinical developmentsMate-Pair Sequencing as a Powerful Clinical Tool for the Characterization of Cancers with a DNA Viral EtiologyEpstein-Barr Virus: Diseases Linked to Infection and TransformationA Review of Management of Inflammation in the HIV PopulationNuclear Factor kappa B is central to Marek's disease herpesvirus induced neoplastic transformation of CD30 expressing lymphocytes in-vivoIsolated central nervous system involvement by lymphomatoid granulomatosis in an adolescent: a case report and review of literature.Association between abnormal serum free light chains ratio and known prognostic factors in lymphoma; a nephrology viewpoint.Nucleofection of DCs to generate Multivirus-specific T cells for prevention or treatment of viral infections in the immunocompromised host.Comprehensively surveying structure and function of RING domains from Drosophila melanogasterHodgkin's Disease in Patients with HIV InfectionBurkitt lymphoma: pathogenesis and immune evasion.EBV, HCMV, HHV6, and HHV7 screening in bone marrow samples from children with acute lymphoblastic leukemia.Carcinogenic viruses and solid cancers without sufficient evidence of causal association.Systemic Epstein-Barr virus positive T-cell lymphoproliferative disease of childhood with hemophagocytic syndrome.Human Immunodeficiency Virus Infection and Hodgkin's Lymphoma in South Africa: An Emerging ProblemInhibition of breast cancer cell proliferation through disturbance of the calcineurin/NFAT pathway by human herpesvirus 6B U54 tegument proteinPrognostic significance of EBV latent membrane protein 1 expression in lymphomas: evidence from 15 studiesHuman-derived IgG level as an indicator for EBV-associated lymphoma model in Hu-PBL/SCID chimeras.Systemic Epstein-Barr-virus-positive T cell lymphoproliferative childhood disease in a 22-year-old Caucasian man: A case report and review of the literatureExpression of dual-specificity phosphatase 5 pseudogene 1 (DUSP5P1) in tumor cellsModulation of cellular signaling by herpesvirus-encoded G protein-coupled receptors.Epstein-Barr virus down-regulates tumor suppressor DOK1 expression.Transcription factor RBPJ/CSL: a genome-wide look at transcriptional regulationInteractions between Hsp90 and oncogenic viruses: implications for viral cancer therapeuticsEBV+ diffuse large B-cell lymphoma arising within atrial myxoma in Chinese immunocompetent patient.No Evidence of XMRV or MuLV Sequences in Prostate Cancer, Diffuse Large B-Cell Lymphoma, or the UK Blood Donor Population.The presence of Epstein-Barr virus significantly impacts the transcriptional profile in immunodeficiency-associated Burkitt lymphoma.Clinical outcome of Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly in the rituximab eraClinicopathologic features of plasmablastic lymphoma: Single-center series of 8 cases from Saudi Arabia.Patient-Derived Tumor Xenografts Are Susceptible to Formation of Human Lymphocytic TumorsScreening and functional analysis of differentially expressed genes in EBV-transformed lymphoblastsMyeloid-derived suppressor cells inhibit T cell proliferation in human extranodal NK/T cell lymphoma: a novel prognostic indicator.LMP1 and LMP2A are potential prognostic markers of extranodal NK/T-cell lymphoma, nasal type (ENKTL).EBV-driven diffuse large B-cell lymphoma confined to the liver in a patient with a history of idiopathic CD4 lymphocytopeniaChemoimmunotherapy and withdrawal of immunosuppression for monomorphic posttransplant lymphoproliferative disorders.Epstein-Barr virus positive diffuse large B-cell lymphoma of the elderly.Implication of human herpesviruses in oncogenesis through immune evasion and supression.
P2860
Q26767186-E25BBE6B-D8CF-4743-982B-0AB638833B0DQ26771672-90092247-E537-48B1-9AA7-F425C4A14E04Q26771869-E1B46F6D-71FD-4B0B-82B4-0B8DFE4C71B8Q26775442-610F1AB7-E128-4ED3-8C42-3590BCDED4DFQ26799320-37C6F365-633A-4506-9791-9F10D956D5AFQ28074586-8812ADE2-1EC8-4A1C-840A-CE654C14F577Q28078962-568CA79B-A979-4868-820B-2E4B2CAB09C1Q31090571-F6BA20B1-858A-443A-A9D7-7AC940518E45Q33536758-56584254-1DB5-4625-AD77-8B1F065D7FB0Q33652326-CF5A1DF9-F194-4FE1-9C28-AC50DFD7FC5BQ33713932-1AD8AB5B-AFC5-4300-A87E-76CC3B4C8C78Q34017765-DF15D128-3C43-40D6-BB68-B66AC3B261E4Q34169941-4E3BF484-0928-4E77-ABAE-FD88794B5275Q34189497-27EB2691-90FD-42D3-9A93-2E1F69F659C7Q34306768-FDEF5F9B-DE4B-40F8-A02F-B581681958E1Q34320412-89C31CF5-EB39-4F63-B0DE-37551511547AQ34501864-4579A930-D9E1-4197-8679-07DC3C43623BQ34571564-20ED26E8-EB99-440C-8760-9F23EAFD99ABQ34593618-FADADA82-B36A-41EE-88FF-7B67EE0B855FQ34683653-1096E2FC-3271-44E2-B922-1898B75E3371Q35003923-9D2405DC-032F-478C-A25A-0F4A67E2E535Q35089229-0F34B09D-5726-40B5-A088-A2212642D933Q35126260-38F23712-CC5F-4838-BE13-54B6036AD067Q35158385-17B8D1DB-9878-46D2-AA5C-D42EDA173AC0Q35165290-22A04ED1-48E9-4687-9A32-535E9536B80AQ35202831-21B25D79-3408-4681-9CAF-F01F7DD6E9AAQ35376259-D9727BF1-633D-4AE0-A2EA-502FCACEEFEFQ35406787-9708CA73-48D4-4C49-8F1F-8C625944B921Q35692351-87B4F9F4-CE3E-401D-A464-CC8AE3E2EACAQ35711180-BB0BC99D-54D7-47AC-9DBA-5AB587212B78Q35713686-83352DEE-E0CD-47CE-B7A0-7B10248B07C5Q35776228-ACFF925F-A634-4AAE-9AB6-33B095C345F8Q36177642-D381EA0E-58DB-4FE9-9931-A4DEE3C98528Q36207171-9C528E9A-1798-414D-9218-726AEE23E4C7Q36275124-981EFA29-1B47-4F20-BA7B-2A6B0383E76CQ36517477-C0024E4D-F7DB-4C5E-AB10-F9F3D4511D89Q37143098-CF247CBA-895E-4051-B821-DBB272BECB90Q37355856-D56481AB-D473-42E0-B0B1-B64C737D2FECQ37405297-22B69788-49D1-4808-916D-822B660CA0F0Q37522705-270C6565-8D53-49AA-AF7A-638B181DFEA6
P2860
EBV-associated lymphoproliferative disorders: classification and treatment.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
EBV-associated lymphoproliferative disorders: classification and treatment.
@en
EBV-associated lymphoproliferative disorders: classification and treatment.
@nl
type
label
EBV-associated lymphoproliferative disorders: classification and treatment.
@en
EBV-associated lymphoproliferative disorders: classification and treatment.
@nl
prefLabel
EBV-associated lymphoproliferative disorders: classification and treatment.
@en
EBV-associated lymphoproliferative disorders: classification and treatment.
@nl
P2093
P1433
P1476
EBV-associated lymphoproliferative disorders: classification and treatment.
@en
P2093
Annunziata Gloghini
Antonino Carbone
Giampietro Dotti
P304
P356
10.1634/THEONCOLOGIST.2008-0036
P577
2008-05-01T00:00:00Z